UNSPSC 51393317: Visnafylline

This classification denotes a bronchodilator with the molecular formula C18H22NO5.C7H7N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GB901PL1KW, chemically known as (2-((9-methoxy-7-methyl-5-oxo-5h-furo(3,2-g)(1)benzopyran-4-yl)oxy)ethyl)trimethylammonium theophylline derivate but generally known as visnafylline, which bears US NIH Compound Identifier 3084273. European Medicines Agency schedules Visnafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00084MIG.

UNSPSC 51393317 Visnafylline (Commodity) does not align with recent state and local procurement activity posted under this code. The two most recent opportunities—a Seminole County, Florida IFB for Naloxone and drug deactivation systems and a Texas Health and Human Services Commission RFI for direct-to-manufacturer pharmacy prescriptions—involve naloxone kits, drug disposal systems, and pharmacy benefit program management, none of which relate to visnafylline, a pharmaceutical vasodilator agent. The code shows minimal relevant recent activity, and the opportunities that do carry this UNSPSC tag appear to be miscoded or represent a data-quality issue in the state and local procurement databases where they were posted.

No state and local solicitations for visnafylline itself appear in the recent opportunity record. Buyers pursuing pharmaceutical procurement should verify code assignment during opportunity research and consider that naloxone and pharmacy-related purchases may be tagged under incorrect UNSPSC categories in issuing-body databases.